12 participants
Phase 1, Single and Repeat Dose Study to Assess Safety, Tolerability, and Pharmacokinetics (PK) of GSK3923868 in Participants With Chronic Obstructive Pulmonary Disease (COPD)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-10-15
- Start Date:
- 2023-01-23
- Completion:
- 2023-07-20
Conditions
- Pulmonary Disease, Chronic Obstructive
Interventions
- DRUG